Insider · CIK 0001656435

Goater Jeff

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001656435

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-08	Surface Oncology, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−129K sh	—	—	0
2022-11-16	LogicBio Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2022-06-17	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-06-08	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2021-07-21	Surface Oncology, Inc.S Sale	Director	SSale	−128K sh	$6.10	−$779K	129,222
2021-06-11	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.3K sh	$4.14	+$42.5K	272,273
2021-06-11	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-06-11	Surface Oncology, Inc.S Sale	Director	SSale	−15.3K sh	$7.61	−$116K	257,000
2021-06-11	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.3K sh	—	—	93,831
2021-06-10	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+200K sh	$4.14	+$828K	462,000
2021-06-10	Surface Oncology, Inc.S Sale	Director	SSale	−235K sh	$7.66	−$1.8M	262,000
2021-06-10	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−200K sh	—	—	104,104
2021-06-10	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−34.7K sh	—	—	10,325
2021-06-10	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.7K sh	$4.14	+$144K	496,727
2021-05-11	VCNXVACCINEX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+28.6K sh	—	—	28,586
2021-04-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+4,425 sh	—	—	4,425
2021-04-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35.4K sh	—	—	35,400
2021-04-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-04-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-02-08	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	247,000
2021-02-08	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$3.18	+$7,950	264,500
2021-02-08	Surface Oncology, Inc.S Sale	Director	SSale	−2,500 sh	$12.50	−$31.3K	262,000
2021-02-01	Surface Oncology, Inc.S Sale	Director	SSale	−2,500 sh	$10.69	−$26.7K	262,000
2021-02-01	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$3.18	+$7,950	264,500
2021-02-01	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	249,500
2021-01-19	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	252,000
2021-01-19	Surface Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$3.18	+$15.9K	267,000
2021-01-19	Surface Oncology, Inc.S Sale	Director	SSale	−5,000 sh	$13.00	−$65K	262,000
2020-12-10	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-14	VCNXVACCINEX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,679
2020-02-05	Surface Oncology, Inc.P Purchase	Director	PPurchase	+5,000 sh	$3.23	+$16.2K	262,000
2020-02-03	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+257K sh	—	—	257,000
2020-02-03	Surface Oncology, Inc.A Award	Director	AAward	+257K sh	—	—	257,000
2019-05-15	VCNXVACCINEX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,718 sh	—	—	7,718
2019-03-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+300K sh	—	—	300,000
2016-02-01	VYGRVoyager Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+25K sh	$11.09	+$277K	65,000
2016-02-01	VYGRVoyager Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	$11.09	+$444K	40,000

Recent filings

Accepted (ET)
Sep 84
Goater Jeff0001209191-23-048758
SEC(opens sec.gov)
Nov 174
Goater Jeff0000899243-22-036298
SEC(opens sec.gov)
Jun 214
Goater Jeff0001209191-22-038236
SEC(opens sec.gov)
Jun 104
Goater Jeff0001209191-22-036144
SEC(opens sec.gov)
Jan 144
Goater Jeff0001209191-22-003400
SEC(opens sec.gov)
Jun 144
Goater Jeff0001209191-21-040429
SEC(opens sec.gov)
Jun 114
Goater Jeff0001209191-21-040078
SEC(opens sec.gov)
May 124
Goater Jeff0000891839-21-000140
SEC(opens sec.gov)
Apr 24
Goater Jeff0001209191-21-024886
SEC(opens sec.gov)
Feb 94
Goater Jeff0001209191-21-009056
SEC(opens sec.gov)

Companies

Address

C/O VOYAGER THERAPEUTICS, INC. 75 SIDNEY STREET

CAMBRIDGE, MA, 02139